In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues [+] | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 |
Royalties | | | | | | | | 0.4 |
Revenue growth | -100.0% | | | | | | -100.0% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 |
Gross profit | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | | 100.0% | | | | | | 0.0% |
Selling, general and administrative [+] | 12.2 | 13.0 | 7.4 | 5.4 | 5.0 | 2.4 | 1.6 | 2.5 |
General and administrative | 12.2 | 13.0 | 7.4 | 5.4 | 5.0 | 2.4 | 1.6 | 2.5 |
Research and development | 5.0 | 5.1 | 5.6 | 5.0 | 1.9 | 0.5 | 0.3 | 0.4 |
EBITDA [+] | | | | | | | | |
Depreciation and amortization | | | | | | | | |
EBIT [+] | -17.2 | -17.9 | -13.0 | -10.4 | -7.0 | -2.9 | -1.9 | -2.9 |
EBIT growth | -3.7% | 37.5% | 25.0% | 49.7% | 142.1% | 51.9% | -34.3% | 49.0% |
EBIT margin | | -10520.6% | | | | | | -824.4% |
Interest income | 0.1 | 0.1 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
Interest income | 0.1 | 0.1 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
Other income (expense), net [+] | -0.2 | -0.3 | -0.1 | 0.2 | -0.1 | 0.1 | 1.2 | 0.7 |
Amortization of financing costs and debt discount | 0.0 | -0.4 | -0.1 | | | | | |
Gain (loss) on sale of assets | | | | | | 0.0 | | |
Unrealized gain/loss on derivatives | | | | 0.2 | -0.1 | 0.0 | 1.2 | 0.4 |
Gain (loss) on foreign currency transactions | | | | | | | | 0.0 |
Other | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 |
Pre-tax income | -17.3 | -18.1 | -12.8 | -9.9 | -7.0 | -2.8 | -0.7 | -2.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -17.3 | -18.1 | -12.8 | -9.9 | -7.0 | -2.8 | -0.7 | -2.2 |
Net margin | | -10652.4% | | | | | | -623.5% |
|
Basic EPS [+] | ($0.67) | ($0.76) | ($0.64) | ($0.52) | ($0.47) | ($0.22) | ($0.06) | ($0.22) |
Growth | -12.7% | 19.0% | 23.0% | 11.2% | 114.8% | 259.0% | -72.4% | -216.1% |
Diluted EPS [+] | ($0.67) | ($0.76) | ($0.64) | ($0.52) | ($0.47) | ($0.22) | ($0.06) | ($0.22) |
Growth | -12.7% | 19.0% | 23.0% | 11.2% | 114.8% | 259.0% | -72.4% | -226.3% |
|
Shares outstanding (basic) [+] | 26.0 | 23.7 | 19.9 | 18.9 | 15.0 | 12.8 | 10.8 | 9.9 |
Growth | 9.7% | 19.1% | 5.0% | 26.2% | 17.6% | 17.9% | 9.7% | 1.6% |
Shares outstanding (diluted) [+] | 26.0 | 23.7 | 19.9 | 18.9 | 15.0 | 12.8 | 10.8 | 9.9 |
Growth | 9.7% | 19.1% | 5.0% | 26.2% | 17.6% | 17.9% | 9.7% | -6.6% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |